Daiichi Sankyo Inc., part of Daiichi Sankyo Co. Ltd., of Tokyo, appointed Antoine Yver global head, oncology research and development. Yver will have responsibility for leading all of the global research and development across the oncology therapeutic area including external investments, internal pipeline decisions and resourcing requirements.